세계의 양막 제품 시장 보고서(2025년)
Amniotic Products Global Market Report 2025
상품코드 : 1824328
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 양막 제품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 8.8%로 확대되어 15억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 비침습적 치료에 대한 환자의 선호도 증가, 만성 상처 유병률 증가, 공동 연구 및 제휴, COVID-19의 영향, 안과 질환 유병률 증가, 건강 관리 지출 증가로 인한 것입니다. 예측기간의 세계 동향에는 제품 기술의 지속적인 진화, 강력한 성장 잠재력, 지역 역학, COVID-19의 영향과 다가오는 세계 불황, 대상 환자 인구 증가, 신흥국 경제 등이 포함됩니다.

향후 5년간의 성장률 8.8%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 오스트리아와 싱가포르에서 조달하는 양수 유래 줄기세포 제품과 성장 인자 주사 비용을 늘리고 치료비를 악화시키고 재생 치료에 대한 접근을 제한함으로써 미국의 재생 의료에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

외상과 사고 사례 증가로 향후 수년간 양막 제품 시장의 성장이 예상됩니다. 외상이란 신속한 치료가 필요한 갑작스런 신체적 손상을 의미하며, 사고는 미끄러짐, 넘어짐, 차량 충돌, 스포츠 외상 등 다양한 의도치 않은 사고를 의미합니다. 예를 들어, 3도 열 화상은 전체 층 피부 절제술과 초건조 인간 양막 상처 코팅을 사용하여 치료됩니다. 예를 들어 2024년 4월 룩셈부르크에 본부를 두고 있는 유럽 연합(EU) 통계국인 Eurostat는 EU 지역 내 교통사고로 인한 사망자 수가 2022년에는 2만 653명으로, 2021년의 1만 9917명에 비해 4% 증가했다고 보고했습니다. 따라서 외상과 사고 사례 증가는 양막 제품 시장의 성장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Amniotic products encompass ortho-biologic solutions that leverage materials derived from amniotic sources, including amniotic membranes and fluid products, to promote healing and reduce inflammation in joints. The application of amniotic products at the site of injury facilitates tissue growth, contributing to the overall recovery process.

The primary categories of amniotic products include amniotic membranes and amniotic suspensions. Amniotic membranes consist of the innermost layer of the placenta, featuring a robust foundation membrane and an avascular stromal matrix. These membranes find applications in surgical dressing for burns, tissue restoration in oral and bladder procedures, as well as interventions such as tympanoplasty, arthroplasty, omphalocele repair, and prevention of adhesions in pelvic and abdominal surgeries. Amniotic products are utilized across medical specialties, including wound care, orthopedics, ophthalmology, and others, with their deployment occurring in hospitals, ambulatory surgical centers, and similar healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The amniotic products market research report is one of a series of new reports from The Business Research Company that provides amniotic products market statistics, including amniotic products industry global market size, regional shares, competitors with an amniotic products market share, detailed amniotic products market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic products industry. This amniotic products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amniotic products market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.08 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of burn injuries, increasing demand for regenerative medicine, growing adoption of amniotic products in surgical wounds, rising awareness of amniotic products as a viable treatment avenue, global expansion of amniotic products.

The amniotic products market size is expected to see strong growth in the next few years. It will grow to $1.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing patient preference for non-invasive therapies, rising prevalence of chronic wounds, collaborations and partnerships, impact of COVID-19, rising prevalence of ophthalmic disorders, increasing healthcare expenditure. Major trends in the forecast period include continuous evolution of product technology, strong growth potential, regional dynamics, impact of COVID-19 and a looming global recession, growth in the target patient population, emerging economies.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. regenerative medicine by driving up the cost of amniotic fluid-derived stem cell products and growth factor injections sourced from Austria and Singapore, exacerbating treatment costs and limiting regenerative therapy access. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of trauma and accident cases is expected to drive the growth of the amniotic products market in the coming years. Trauma refers to sudden physical injuries that require immediate medical attention, while accidents include various unintentional incidents, such as slips, falls, vehicle collisions, or sports injuries. Third-degree burn injuries, for instance, are treated using full-thickness skin excision and hyper-dry human amniotic membrane wound dressings. For example, in April 2024, Eurostat, a Luxembourg-based statistical office of the European Union, reported that road traffic accidents in the EU led to 20,653 fatalities in 2022, a 4% increase compared to the 19,917 deaths in 2021. Thus, the rising number of trauma and accident cases is fueling the growth of the amniotic products market.

The growing demand for surgical procedures is expected to further propel the growth of the amniotic products market. Surgical procedures involve medical interventions performed by qualified surgeons to treat, repair, remove, or replace parts of the body affected by disease or injury. Amniotic products are advantageous in surgical procedures as they promote tissue regeneration and healing, minimize inflammation at surgical sites, contribute to faster recovery, reduce postoperative pain, and improve tissue repair and protection. For instance, in June 2024, the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery organization, reported that liposuction was the most popular plastic surgery in 2023, with nearly 350,000 procedures performed, marking a 7% increase from 2022. Additionally, hand surgeries totaled 207,887, a 2% increase, while maxillofacial surgeries reached 52,868, up 1% compared to the previous year. Consequently, the rising demand for surgical procedures is driving the growth of the amniotic products market.

Innovation stands as a central trend propelling advancements in the amniotic products market. Key industry players are focusing on developing pioneering products to fortify their standing within this competitive landscape. For example, Versea Health Inc., a US-based life science company, introduced Biovance 3L ocular tri-layer human amniotic membrane in November 2022. This product, available in sheet and disc forms, specifically targets surgical and ocular segments. Biovance 3L and Biovance 3L Ocular are tri-layer human amniotic membrane products designed to offer an extracellular matrix for biological membrane covering, fostering healing and tissue growth during wound recovery.

Major companies in the amniotic products market are directing their efforts towards innovative solutions such as dual-layer allografts to drive market growth and bolster revenues. Dual-layer allografts serve patients with complex surgical wounds, burns, and non-healing acute or chronic wounds. For instance, in February 2022, Amnio Technology LLC, a US-based company specializing in amnion-derived technologies, unveiled the palingen dual-layer membrane and dual-layer palingen X-membrane. These advanced allografts target challenging surgical wounds and leverage a dual-layered structure. The design utilizes two Advantek processes, ensuring unidirectional application while preserving the crucial regulatory proteins and extracellular matrix constituents inherent in amniotic tissue. The dual-layer construction and specialized Advantek processes in palingen membranes safeguard the regulatory proteins and extracellular matrix constituents, enhancing their effectiveness in addressing challenging wounds and facilitating tissue repair and regeneration.

In July 2022, Sanara MedTech Inc., a US-based medical technology firm, acquired Scendia Biologics, LLC, for $0.0074 billion. This acquisition is intended to expand Sanara's product portfolio in surgical and chronic wound care by incorporating a substantial range of advanced biologic products, which will ultimately enhance patient outcomes and lower overall costs. Scendia Biologics, LLC, a US-based provider, specializes in high-quality regenerative and fusion technologies, including amniotic products.

Major companies operating in the amniotic products market include Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Lucina BioSciences LLC, Bioventus LLC, Organogenesis Inc., MiMedx Group, AlloSource, Orthofix US LLC, ACell Inc., Aziyo Biologics Inc., TissueTech Inc., Amino Technology LLC, LifeCell International Pvt. Ltd., Tissue Regenix Group plc, Aroa Biosurgery Limited, Skye Biologics Inc., Celularity Inc., NuVision Biotherapies Ltd., VIVEX Biologics Inc., Genesis Biologics Inc., Applied Biologics LLC, Next Biosciences, Surgenex LLC

North America was the largest region in the amniotic products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amniotic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amniotic products market consists of sales of amniotic tissue matrix and amniotic fluid cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amniotic Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amniotic products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for amniotic products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amniotic products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Amniotic Products Market Characteristics

3. Amniotic Products Market Trends And Strategies

4. Amniotic Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Amniotic Products Growth Analysis And Strategic Analysis Framework

6. Amniotic Products Market Segmentation

7. Amniotic Products Market Regional And Country Analysis

8. Asia-Pacific Amniotic Products Market

9. China Amniotic Products Market

10. India Amniotic Products Market

11. Japan Amniotic Products Market

12. Australia Amniotic Products Market

13. Indonesia Amniotic Products Market

14. South Korea Amniotic Products Market

15. Western Europe Amniotic Products Market

16. UK Amniotic Products Market

17. Germany Amniotic Products Market

18. France Amniotic Products Market

19. Italy Amniotic Products Market

20. Spain Amniotic Products Market

21. Eastern Europe Amniotic Products Market

22. Russia Amniotic Products Market

23. North America Amniotic Products Market

24. USA Amniotic Products Market

25. Canada Amniotic Products Market

26. South America Amniotic Products Market

27. Brazil Amniotic Products Market

28. Middle East Amniotic Products Market

29. Africa Amniotic Products Market

30. Amniotic Products Market Competitive Landscape And Company Profiles

31. Amniotic Products Market Other Major And Innovative Companies

32. Global Amniotic Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amniotic Products Market

34. Recent Developments In The Amniotic Products Market

35. Amniotic Products Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기